UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or other jurisdiction ...

财务数据和关键指标变化 - 公司第一季度调整后EBITDA为31.7亿美元,同比增长近8% [15][16] - 每股摊薄收益(不含出售设施损失)增长近20%至4.93美元 [8][9] - 公司现金流从上年同期的13.5亿美元增加到18亿美元 [20] - 资本支出约为11.8亿美元 [21] 各条业务线数据和关键指标变化 - 同院入院量同比增长4.4%,其中非COVID-19入院量增长12% [9] - 同院门诊就诊量同比增长7.5%,其中急诊就诊量增长10%,门诊手术量增长5% [9] - 门诊心脏病手术量增长7% [10] - 公司整体收入同比增长5% [10] 各个市场数据和关键指标变化 - 公司在某些市场如圣安东尼奥的平均占床率约为90%,需要新建医院来满足需求 [69][70] - 公司正在收购土地在达拉斯、拉斯维加斯、盐湖城等市场建设新医院 [69][70] 公司战略和发展方向及行业竞争 - 公司继续投资于网络、人员和技术,以提高服务能力和提供优质护理 [13] - 公司正在扩大门诊网络,目前拥有约2,500家门诊设施 [69] - 公司正在投资于新的医院建设,以满足不断增长的需求 [69][70] 管理层对经营环境和未来前景的评论 - 公司在第四季度末开始的强劲需求势头延续至第一季度 [8] - 管理层对公司的运营势头和未来前景持乐观态度,提高了全年指引 [13] - 公司相信其在网络、人员和技术方面的投资将提供必要的资源,以改善服务并为患者提供优质护理 [13] 问答环节重要的提问和回答 问题1 **A.J. Rice 提问** 公司在第一季度表现出色,未来一年的变量有哪些?是否存在劳动力和需求方面的不确定性? [29][30][31][32] **Bill Rutherford 回答** 公司对市场需求前景持乐观态度,并已将此反映在更新的全年指引中。在成本管控方面,公司正在努力降低合同工使用,并继续投资于员工薪酬和培训计划。总体来看,公司对全年前景保持信心。 [30][31][32][33] 问题2 **Whit Mayo 提问** 公司门诊手术量在医院门诊部和独立手术中心的增长情况如何?以及供应成本保持良好的原因? [37][38][39] **Sam Hazen 回答** 公司门诊手术量在两个渠道都有较强增长,增幅基本持平。这得益于公司持续投资于两个渠道的发展。同时,公司的供应链管理能力出色,有效控制了供应成本。 [38][39] 问题3 **Justin Lake 提问** 公司合同工使用比例下降21%,未来的目标水平是多少?这部分节省会如何投入? [41][42][43][44] **Bill Rutherford 回答** 公司希望到年底将合同工使用比例降至6.5%-7%左右,这与公司之前的目标基本一致。节省的资金主要用于提高员工薪酬和招聘,而不会大幅增加利润率。 [42][43][44]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11239 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 27-3865930 (State or Other Jurisdiction of I ...

HCA Healthcare, Inc. (NYSE:HCA) Q4 2022 Earnings Conference Call January 27, 2023 10:00 AM ET Company Participants Frank Morgan - Vice President, Investor Relations Sam Hazen - Chief Executive Officer Bill Rutherford - Chief Financial Officer Conference Call Participants Justin Lake - Wolfe Research A.J. Rice - Credit Suisse Gary Taylor - Cowen Ben Hendrix - RBC Capital Markets Whit Mayo - SVB Securities Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Ann Hynes - Mizuho Securities Brian Ta ...

1 Investor Update Q3 2022 Forward looking statements and non-GAAP financial measures 2 This presentation contains certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, financial results, cash flows , costs and ...

1 Investor Update Q3 2022 Forward looking statements and non-GAAP financial measures 2 This presentation contains certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, financial results, cash flows , costs and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or other jurisdic ...

HCA Healthcare, Inc. (NYSE:HCA) Q3 2022 Results Conference Call October 21, 2022 9:00 AM ET Company Participants Frank Morgan - VP, IR Sam Hazen - CEO Bill Rutherford - CFO Conference Call Participants A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Ann Hynes - Mizuho Securities Justin Lake - Wolfe Research Gary Taylor - Cowen Andrew Mok - UBS Whit Mayo - SVB Securities Ben Hendrix - RBC Capital Markets Lance Wilkes - Bernstein Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Scott Fi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or other jurisdiction ...

HCA Healthcare, Inc. (NYSE:HCA) Q2 2022 Earnings Conference Call July 22, 2022 9:00 AM ET Company Participants Frank Morgan - Vice President, Investor Relations Samuel Hazen - Chief Executive Officer William Rutherford - Executive Vice President and Chief Financial Officer Conference Call Participants A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Ann Hynes - Mizuho Securities Whit Mayo - SVB Securities Gary Taylor - Cowen Joanna Gajuk - Bank of America Justin Lake - Wolfe Research Ben Hendrix - ...